RituximabLack of efficacy in off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1946卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35093-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：492 / 492

相关论文

共 50 条

[1] RituximabLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1905 (1) : 444 - 444
[2] RituximabLack of efficacy and off-label: case report
[J]. Reactions Weekly, 2022, 1932 (1) : 522 - 522
[3] Prednisolone/rituximabLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1878 (1) : 445 - 445
[4] Apixaban/dexamethasone/rituximabLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 219 - 219
[5] COVID-19 vaccine/rituximabLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 237 - 237
[6] Obinutuzumab/rituximabLack of efficacy following off-label use: 3 case reports
[J]. Reactions Weekly, 2022, 1913 (1) : 357 - 357
[7] Bendamustine/polatuzumab-vedotin/rituximabLack of efficacy following an off-label use: case report
[J]. Reactions Weekly, 2022, 1935 (1) : 113 - 113
[8] Daratumumab/dexamethasone/rituximabLack of efficacy and off-label use: 5 case reports
[J]. Reactions Weekly, 2021, 1873 (1) : 96 - 96
[9] Abatacept/ofatumumab/rituximabLack of efficacy and off label use: case report
[J]. Reactions Weekly, 2022, 1930 (1) : 13 - 13
[10] AntiviralsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1976 (1) : 48 - 48

← 1 2 3 4 5 →